Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guiming Chen

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|September 5, 2022
Downregulation of ZNF280A inhibits proliferation and tumorigenicity of colorectal cancer cells by promoting the ubiquitination and degradation of RPS14Binle Tian, Jingyi Zhou, Guiming Chen, et al.
Molecular Medicine Reports|August 2, 2018
Knockdown of miR‑935 increases paclitaxel sensitivity via regulation of SOX7 in non‑small‑cell lung cancerBing Peng, Chao Li, Peng Cai, et al.
Molecular and Cellular Probes|February 10, 2025
Serum exosomal miR-454-3p contributes to malignant progression of lung cancer by inhibiting HHEXGangqin Hu, Peng Cai, Jingjing Li, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
Molecular subtypes predict the prognosis of male breast cancer: a retrospective cohort studyMin Wang, Deyue Liu, Zhaoqi Zhang, et al.
Journal of Thoracic Disease|June 16, 2023
Prediction of target genes in community-acquired pneumonia based on the bioinformatics methodYangsong Zuo, Wenyi Shen, Guiming Chen, et al.
Medical Oncology (Northwood, London, England)|October 5, 2014
Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapyGuiming Chen, Jin Peng, Weiguo Zhu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 30, 2020
Reabsorption of bile acids regulated by FXR-OATP1A2 is the main factor for the formation of cholesterol gallstoneJingli Cai, Zhaowen Wang, Guiming Chen, et al.
Oncology Letters|March 21, 2020
MicroRNA-107 may regulate lung cancer cell proliferation and apoptosis by targeting TP53 regulated inhibitor of apoptosis 1Peng Cai, Jingjing Li, Guiming Chen, et al.
American Journal of Translational Research|June 21, 2021
High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapyChuanhui Xu, Jinhui Yu, Feifei Wu, et al.
American Journal of Translational Research|August 10, 2023
Erratum: High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapyChuanhui Xu, Jinhui Yu, Feifei Wu, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|September 5, 2022
Downregulation of ZNF280A inhibits proliferation and tumorigenicity of colorectal cancer cells by promoting the ubiquitination and degradation of RPS14Binle Tian, Jingyi Zhou, Guiming Chen, et al.
Molecular Medicine Reports|August 2, 2018
Knockdown of miR‑935 increases paclitaxel sensitivity via regulation of SOX7 in non‑small‑cell lung cancerBing Peng, Chao Li, Peng Cai, et al.
Molecular and Cellular Probes|February 10, 2025
Serum exosomal miR-454-3p contributes to malignant progression of lung cancer by inhibiting HHEXGangqin Hu, Peng Cai, Jingjing Li, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
Molecular subtypes predict the prognosis of male breast cancer: a retrospective cohort studyMin Wang, Deyue Liu, Zhaoqi Zhang, et al.
Journal of Thoracic Disease|June 16, 2023
Prediction of target genes in community-acquired pneumonia based on the bioinformatics methodYangsong Zuo, Wenyi Shen, Guiming Chen, et al.
Medical Oncology (Northwood, London, England)|October 5, 2014
Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapyGuiming Chen, Jin Peng, Weiguo Zhu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 30, 2020
Reabsorption of bile acids regulated by FXR-OATP1A2 is the main factor for the formation of cholesterol gallstoneJingli Cai, Zhaowen Wang, Guiming Chen, et al.
Oncology Letters|March 21, 2020
MicroRNA-107 may regulate lung cancer cell proliferation and apoptosis by targeting TP53 regulated inhibitor of apoptosis 1Peng Cai, Jingjing Li, Guiming Chen, et al.
American Journal of Translational Research|June 21, 2021
High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapyChuanhui Xu, Jinhui Yu, Feifei Wu, et al.
American Journal of Translational Research|August 10, 2023
Erratum: High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapyChuanhui Xu, Jinhui Yu, Feifei Wu, et al.
Pageof 4